Panax notoginseng saponins attenuate lung cancer growth in part through modulating the level of Met/miR-222 axis
- 24 August 2016
- journal article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 193, 255-265
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Institutions of Higher Learning (GZ2015011, Hu201188)
- National Natural Science Foundation of China (81273960 and 81400313)
This publication has 45 references indexed in Scilit:
- A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor AngiogenesisCancer Cell, 2013
- Global cancer transitions according to the Human Development Index (2008–2030): a population-based studyThe Lancet Oncology, 2012
- Antioxidant, Antiproliferative, and Pro-Apoptotic Activities of a Saponin Extract Derived from the Roots of Panax notoginseng (Burk.) F.H. ChenJournal of Medicinal Food, 2012
- SCD1 Inhibition Causes Cancer Cell Death by Depleting Mono-Unsaturated Fatty AcidsPLOS ONE, 2012
- Rapamycin Regulates Stearoyl CoA Desaturase 1 Expression in Breast CancerMolecular Cancer Therapeutics, 2010
- RETRACTED: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 DownregulationCancer Cell, 2009
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferationThe EMBO Journal, 2007
- Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cellsCancer Chemotherapy and Pharmacology, 2006
- The functions of animal microRNAsNature, 2004